Cheryl Cohen sold $851K of ImmunityBio (IBRX)

Executed Oct 2, disclosed Oct 6, 4 days later.

Value, as filed

$851K

81,056 sh × $10.50

Executed

Oct 2

the trade date, as filed

Disclosed

Oct 6

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CC Cheryl Cohen Director profile →

Cheryl Cohen (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.2M of IBRX (131,210 sh × $9.50, as filed), executed Jul 2.

The name

IBRX ImmunityBio, Inc. IBRX · Healthcare · 13 filings in 24 months ticker →

Healthcare · ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Cheryl Cohen in IBRX

IBRXSALE ImmunityBio, Inc. $1.2M
131,210 sh × $9.50
Exec Jul 2
Filed Jul 6 · 8:26 PM ET